Foundations Investment Advisors LLC Takes $54.51 Million Position in iShares U.S. Pharmaceuticals ETF $IHE

Foundations Investment Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 642,617 shares of the company’s stock, valued at approximately $54,513,000. Foundations Investment Advisors LLC owned 0.06% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ellerson Group Inc. ADV acquired a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $222,000. Harbour Investments Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 260.5% in the fourth quarter. Harbour Investments Inc. now owns 1,799 shares of the company’s stock valued at $153,000 after acquiring an additional 1,300 shares during the last quarter. Accent Capital Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $42,000. Axxcess Wealth Management LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 27.7% in the fourth quarter. Axxcess Wealth Management LLC now owns 9,062 shares of the company’s stock valued at $769,000 after acquiring an additional 1,968 shares during the last quarter. Finally, Global Retirement Partners LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 194.7% in the fourth quarter. Global Retirement Partners LLC now owns 837 shares of the company’s stock valued at $71,000 after acquiring an additional 553 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.7%

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $91.87 on Thursday. iShares U.S. Pharmaceuticals ETF has a twelve month low of $63.76 and a twelve month high of $92.48. The stock has a market capitalization of $992.20 million, a P/E ratio of 17.75 and a beta of 0.49. The business’s fifty day moving average price is $87.36 and its 200 day moving average price is $86.55.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.